FDA Inspection
Ionetix CorporationIonetix Corporation – FDA Inspection, Apr 2, 2026
Record Details
This FDA Inspection record concerns Ionetix Corporation, with an inspection on April 2, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 81267fe9-02cb-4e15-bb8b-4823d6765f11
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1310614
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 212.20(c)Specifications and processes
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.40(c)Use of reliable suppliers
- 21 CFR 212.50(a)Written control procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ionetix Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ionetix Corporation
- FDA Inspection 1110261 - 2019-10-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.